Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 1.0100
- +0.0100+1.00%
Close Dec 13 16:00 ET
186.30MMarket Cap-1.20P/E (TTM)
1.0300High0.9900Low2.06MVolume1.0000Open1.0000Pre Close2.08MTurnover1.24%Turnover RatioLossP/E (Static)184.46MShares1.928052wk High3.81P/B168.08MFloat Cap0.460852wk Low--Dividend TTM166.42MShs Float111.3600Historical High--Div YieldTTM4.00%Amplitude0.4126Historical Low1.0090Avg Price1Lot Size
Nektar Therapeutics News
Nektar Therapeutics | 8-K: Current report
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Eventide Asset Management, LLC(5.11%),Finny Kuruvilla, M.D. Ph. D.(5.11%), etc.
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(8.65%),Deep Track Biotechnology Master Fund, Ltd.(8.65%), etc.
Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(8.7%)
Nektar Therapeutics | 10-Q: Q3 2024 Earnings Report
Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Third Quarter 2024 Financial Results
Nektar Therapeutics | 8-K: Current report
Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(8.7%)
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nektar Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.